Jon Meltzer, Ph.D., is Executive Vice President of Operations at Labcorp, where he oversees the company’s diagnostics lab operations and global supply chain.
Jon joined Labcorp in 2006 and has held leadership roles of increasing responsibility. Most recently, he served as Senior Vice President of Laboratory Operations leading operations across more than 30 laboratory locations and oversight of the P&Ls for the Esoteric business units.
Previously, he served as Senior Vice President of Strategy, Senior Vice President of Esoteric Businesses, Senior Vice President of Specialty Oncology as well as Vice President of Corporate Development, where he managed licensing, partnerships, mergers and acquisitions, and led the Labcorp Venture Fund. Jon also played a pivotal role in Labcorp’s pandemic response, directing efforts that delivered more than 70 million COVID-19 PCR tests and supported next-generation sequencing surveillance for the U.S. Centers for Disease Control and Prevention.
Before joining Labcorp, Jon worked in venture capital, the Duke Office of Licensing and Ventures, and the North Carolina Department of the State Treasurer. Earlier in his career, he served as a Technology Commercialization Officer at the National Research Council of Canada and co-founded a company manufacturing molecular reagents for biomedical research.
Jon holds his Bachelor of Science and a Doctorate in anatomy from the University of Manitoba and a Master of Business Administration from Duke University’s Fuqua School of Business.
What is Jonathan C. Meltzer's net worth?
The estimated net worth of Jonathan C. Meltzer is at least $769.31 thousand as of February 12th, 2026. Meltzer owns 2,782 shares of Labcorp stock worth more than $769,306 as of February 17th. This net worth approximation does not reflect any other assets that Meltzer may own. Learn More about Jonathan C. Meltzer's net worth.
How do I contact Jonathan C. Meltzer?
Has Jonathan C. Meltzer been buying or selling shares of Labcorp?
During the last quarter, Jonathan C. Meltzer has sold $25,266.54 in shares of Labcorp stock. Most recently, Jonathan C. Meltzer sold 87 shares of the business's stock in a transaction on Thursday, February 12th. The shares were sold at an average price of $290.42, for a transaction totalling $25,266.54. Following the completion of the sale, the executive vice president now directly owns 2,782 shares of the company's stock, valued at $807,948.44. Learn More on Jonathan C. Meltzer's trading history.
Who are Labcorp's active insiders?
Labcorp's insider roster includes Kerrii Anderson (Director), Jean-Luc Belingard (Director), Lance Berberian (EVP), Brian Caveney (EVP), Jonathan DiVincenzo (EVP and President, Central Laboratories and International), Glenn Eisenberg (CFO), Dwight Gilliland (Director), Paul Kirchgraber (CEO), Jonathan Meltzer (EVP), Peter Neupert (Director), Richelle Parham (Director), Adam Schechter (Chairman, President, and CEO), Mark Schroeder (EVP), Amy Summy (CMO), Sandra van der Vaart (EVP), Peter Wilkinson (CAO), and R. Williams (Director). Learn More on Labcorp's active insiders.
Are insiders buying or selling shares of Labcorp?
During the last year, insiders at the medical research company sold shares 19 times. They sold a total of 53,131 shares worth more than $13,840,813.97. The most recent insider tranaction occured on February, 12th when EVP Jonathan C Meltzer sold 87 shares worth more than $25,266.54. Insiders at Labcorp own 0.8% of the company.
Learn More about insider trades at Labcorp. Information on this page was last updated on 2/12/2026.
